Key principles for the use of electronic product information for EU medicines

29 January 2020 – On 29 January 2020, the European Medicines Agency (EMA) published key principles outlining a harmonized approach to develop and use electronic product information (ePI) for human medicines across the European Union. Digital platforms now open the possibility to disseminate the product information electronically. This can address some of the current limitations and better meet patients’ and healthcare professionals’ needs for accessible, trustworthy and up-to-date information on medicines available at the right time. The key principles explain how ePI will comply with the existing legislative framework. For further information, see here.